22Jun 2023
Metabolomic differences in connective tissue disease‐associated versus idiopathic pulmonary arterial hypertension in the PVDOMICS cohort

Metabolomic differences in connective tissue disease‐associated versus idiopathic pulmonary arterial hypertension in the PVDOMICS cohort

Patients with connective tissue disease‐associated pulmonary arterial hypertension (CTD‐PAH) have poorer survival and respond less to treatment than those with idiopathic PAH (IPAH). A study compared the metabolomic profiles of CTD-PAH and IPAH patients, finding differences in lipid metabolism. The study findings suggest altered metabolic substrate utilization in CTD-PAH and reduced capacity for mitochondrial beta-oxidation in pulmonary circulation.

  • #rheumatology

Like

Save

Share